MORRISVILLE, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary ...
Michelle Hilaire, interim dean of the College of Health Sciences, says the staff was proud of the UW WWAMI medical students’ ...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...
Tuesday, LSU Health Shreveport's School of Medicine showcased their Summer research findings during their annual Fall poster ...
PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...
--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacialâ„¢, announced today that a video poster abstract presentation ... those in the medical field." ...
Si Fang. Poster presentation. Genetically proxied PCSK9 inhibition provides indications of lower prostate cancer risk: a Mendelian randomization study. Target Validation using Genomics and Informatics ...
HUNTINGTON More than 200 students and post-doctoral residents and fellows participated in the 36th annual Marshall University Health Sciences Research Day on Nov. 1 at Marshall University Medical ...
Oral Poster Presentation Title ... hospitals and outpatient clinics for patients at risk for bleeding. A private medical technologies company, Perosphere is focused on development and ...
Philadelphia, Pennsylvania and Oxford, United Kingdom-- (Newsfile Corp. - November 5, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor ...